Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children. - Carbonell-Estrany X; Simões EAF; Bont L; Manzoni P; Zar HJ; Greenough A; Ramilo O; Stein R; Law B; Mejias A; Sanchez Luna M; Checchia PA; et al. (Expert review of anti-infective therapy, 2025)